Yelin Lapidot Holdings Management Ltd. Has $5.16 Million Stake in InMode Ltd. (NASDAQ:INMD)

Yelin Lapidot Holdings Management Ltd. boosted its stake in shares of InMode Ltd. (NASDAQ:INMD) by 0.6% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 308,852 shares of the healthcare company’s stock after purchasing an additional 1,950 shares during the quarter. InMode comprises 0.9% of Yelin Lapidot Holdings Management Ltd.’s portfolio, making the stock its 29th largest holding. Yelin Lapidot Holdings Management Ltd. owned approximately 0.37% of InMode worth $5,158,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Atlas Legacy Advisors LLC bought a new position in shares of InMode in the fourth quarter worth about $848,000. D.A. Davidson & CO. lifted its stake in InMode by 5.7% during the fourth quarter. D.A. Davidson & CO. now owns 43,651 shares of the healthcare company’s stock worth $729,000 after purchasing an additional 2,373 shares during the period. Principal Financial Group Inc. boosted its stake in InMode by 14.6% in the 4th quarter. Principal Financial Group Inc. now owns 99,562 shares of the healthcare company’s stock valued at $1,663,000 after buying an additional 12,661 shares in the last quarter. Harvey Capital Management Inc. raised its stake in InMode by 1.4% during the fourth quarter. Harvey Capital Management Inc. now owns 51,490 shares of the healthcare company’s stock worth $860,000 after acquiring an additional 700 shares in the last quarter. Finally, Meritage Portfolio Management lifted its holdings in InMode by 12.3% during the 4th quarter. Meritage Portfolio Management now owns 16,575 shares of the healthcare company’s stock valued at $277,000 after purchasing an additional 1,810 shares during the last quarter. Institutional investors and hedge funds own 68.04% of the company’s stock.

InMode Stock Performance

NASDAQ INMD opened at $18.57 on Friday. InMode Ltd. has a 52 week low of $14.87 and a 52 week high of $23.46. The stock’s 50 day moving average price is $17.52 and its two-hundred day moving average price is $17.37. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 7.90 and a beta of 2.13.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on INMD shares. Needham & Company LLC reaffirmed a “hold” rating on shares of InMode in a report on Tuesday, February 4th. Barclays raised their price target on InMode from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Wednesday, February 5th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $22.25.

About InMode

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.